Edition:
United Kingdom

Edwards Lifesciences Corp (EW.N)

EW.N on New York Stock Exchange

212.04USD
23 Aug 2019
Change (% chg)

$-4.63 (-2.14%)
Prev Close
$216.67
Open
$216.67
Day's High
$217.37
Day's Low
$210.88
Volume
288,078
Avg. Vol
329,979
52-wk High
$226.31
52-wk Low
$136.47

About

Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan... (more)

Overall

Beta: 0.49
Market Cap(Mil.): $23,535.67
Shares Outstanding(Mil.): 211.16
Dividend: --
Yield (%): --

Financials

  EW.N Industry Sector
P/E (TTM): 33.76 192.03 32.67
EPS (TTM): 3.30 -- --
ROI: 17.58 9.68 14.48
ROE: 26.47 15.56 15.78

FDA pegs Edwards Lifesciences Sapien delivery system recall as severest

The U.S. health regulator on Thursday categorized the recall of Edwards Lifesciences Corp's Sapien 3 Ultra delivery system as extremely serious, highlighting health risks associated with its use, but the products will remain on the market.

22 Aug 2019

UPDATE 2-FDA pegs Edwards Lifesciences Sapien delivery system recall as severest

Aug 22 The U.S. health regulator on Thursday categorized the recall of Edwards Lifesciences Corp's Sapien 3 Ultra delivery system as extremely serious, highlighting health risks associated with its use, but the products will remain on the market.

22 Aug 2019

Edwards Lifesciences recalls delivery system for Sapien heart valves

Aug 22 Medical device maker Edwards Lifesciences Corp is recalling its Sapien 3 Ultra delivery system after burst balloons during implantation led to several injuries and a death, said the U.S. Food and Drug Administration on Thursday.

22 Aug 2019

UPDATE 1-Edwards Lifesciences, Medtronic heart valves win U.S. approval for expanded use

Aug 16 Heart valve systems from Edwards Lifesciences Corp and Medtronic Plc have been approved for use in a condition that restricts blood flow from the heart in patients at low-risk of death linked to open-heart surgeries, the U.S. FDA said on Friday.

16 Aug 2019

Edwards Lifesciences, Medtronic heart valves win FDA approval for expanded use

Heart valve systems from Edwards Lifesciences Corp and Medtronic Plc have been approved for use in a condition that restricts blood flow from the heart in patients at low-risk of death linked to open-heart surgeries, the FDA said on Friday.

16 Aug 2019

Edwards Lifesciences, Medtronic heart valves win FDA approval for expanded use

Aug 16 Heart valve systems from Edwards Lifesciences Corp and Medtronic Plc have been approved for use in a condition that restricts blood flow from the heart in patients at low-risk of death linked to open-heart surgeries, the FDA said on Friday.

16 Aug 2019

FDA ties three deaths to Edwards Lifesciences' recalled heart devices

The U.S. Food and Drug Administration said on Monday three deaths had been reported related to Edwards Lifesciences Corp's recall of some of its heart devices.

02 Jul 2019

UPDATE 2-FDA ties three deaths to Edwards Lifesciences' recalled heart devices

July 1 The U.S. Food and Drug Administration said on Monday three deaths had been reported related to Edwards Lifesciences Corp's recall of some of its heart devices.

02 Jul 2019

FDA says three deaths related to Edwards Lifesciences' recalled heart devices

July 1 The U.S. Food and Drug Administration said on Monday three deaths had been reported related to Edwards Lifesciences Corp's recall of some of its heart devices.

01 Jul 2019

Edwards, Medtronic heart valve systems prove worth in low-risk patients -studies

Non-invasive heart valve replacement systems from Medtronic Plc and rival Edwards Lifesciences Corp proved as good or better than open heart surgery in younger, more active patients for whom the surgical option was deemed low risk, according to trial results that had been scheduled to be presented on Sunday.

16 Mar 2019
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates